loadpatents
Patent applications and USPTO patent grants for Matassa; Victor Giulio.The latest application filed is for "pyrrolotriazinone derivatives as pi3k inhibitors".
Patent | Date |
---|---|
Pyrrolotriazinone derivatives as inhibitors P13K Grant 9,340,547 - Bernal Anchuela , et al. May 17, 2 | 2016-05-17 |
Pyrrolotriazinone Derivatives As Pi3k Inhibitors App 20150099752 - Bernal Anchuela; Francisco Javier ;   et al. | 2015-04-09 |
Pyrrolotriazinone Derivatives As P13k Inhibitors App 20140163033 - Bernal Anchuela; Francisco Javier ;   et al. | 2014-06-12 |
Imidazopyridine Derivatives As Jak Inhibitors App 20130216498 - Eastwood; Paul Robert ;   et al. | 2013-08-22 |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptors Grant 8,178,679 - Matassa , et al. May 15, 2 | 2012-05-15 |
Substituted Indolin-2-one Derivatives And Their Use As P38 Mitogen-activated Kinase Inhibitors App 20110046097 - Eastwood; Paul Robert ;   et al. | 2011-02-24 |
Dpp-Iv Inhibitors App 20080275086 - Edwards; Paul John ;   et al. | 2008-11-06 |
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,417,064 - Boulet , et al. August 26, 2 | 2008-08-26 |
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake Grant 7,410,996 - Boulet , et al. August 12, 2 | 2008-08-12 |
Dpp-IV Inhibitors App 20080176838 - Edwards; Paul John ;   et al. | 2008-07-24 |
Dpp-IV Inhibitors App 20080015146 - Edwards; Paul John ;   et al. | 2008-01-17 |
[1,2,4]Triazolo[4,3-A]Pyridine Derivatives for the Treatment of Hyperproliferative Diseases App 20070299103 - Abel; Ulrich ;   et al. | 2007-12-27 |
Dpp-IV Inhibitors App 20070265261 - Edwards; Paul John ;   et al. | 2007-11-15 |
Dpp-IV Inhibitors App 20070265301 - Edwards; Paul John ;   et al. | 2007-11-15 |
Dpp-iv inhibitors App 20070197522 - Edwards; Paul John ;   et al. | 2007-08-23 |
Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors App 20070099927 - Feurer; Achim ;   et al. | 2007-05-03 |
Peptides and their use as inhibitors of hepatitis C virus ns3 protease Grant 7,119,073 - Colarusso , et al. October 10, 2 | 2006-10-10 |
3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake App 20060014779 - Boulet; Serge Louis ;   et al. | 2006-01-19 |
Peptides and their use as inhibitors of hepatitis c virus ns3 protease App 20040142876 - Colarusso, Stefania ;   et al. | 2004-07-22 |
Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists Grant 6,025,374 - Castro Pineiro , et al. February 15, 2 | 2000-02-15 |
Azetidine, pyrrolidine and piperidine derivatives Grant 5,854,268 - Baker , et al. December 29, 1 | 1998-12-29 |
Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT.sub.1D receptor agonists Grant 5,849,746 - Chambers , et al. December 15, 1 | 1998-12-15 |
Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors Grant 5,696,110 - Bourrain , et al. December 9, 1 | 1997-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.